Free Access
Med Sci (Paris)
Volume 30, Number 5, Mai 2014
Page(s) 508 - 510
Section Nouvelles
Published online 13 June 2014
  1. Euler Z, van den Kerkhof TL, van Gils MJ, et al. Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity. J Virol 2012 ; 86 : 2045–2055. [CrossRef] [PubMed] [Google Scholar]
  2. Klein F, Mouquet H, Dosenovic P, et al. Antibodies in HIV-1 vaccine development and therapy. Science 2013 ; 341 : 1199–1204. [CrossRef] [PubMed] [Google Scholar]
  3. Sourisseau M, Sol-Foulon N, Porrot F, et al. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol 2007 ; 81 : 1000–1012. [CrossRef] [PubMed] [Google Scholar]
  4. Dale BM, Alvarez RA, Chen BK. Mechanisms of enhanced HIV spread through T-cell virological synapses. Immunol Reviews 2013 ; 251 : 113–124. [CrossRef] [Google Scholar]
  5. Rudnicka D, Feldmann J, Porrot F, et al. Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol 2009 ; 83 : 6234–6246. [CrossRef] [PubMed] [Google Scholar]
  6. Sigal A, Kim JT, Balazs AB, et al. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature 2011 ; 477 : 95–98. [CrossRef] [PubMed] [Google Scholar]
  7. Malbec M, Porrot F, Rua R, et al. Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission. J Exp Med 2013 ; 210 : 2813–2821. [CrossRef] [PubMed] [Google Scholar]
  8. Barouch DH, Whitney JB, Moldt B, et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 2013 ; 503 : 224–228. [PubMed] [Google Scholar]
  9. Shingai M, Nishimura Y, Klein F, et al. Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia. Nature 2013 ; 503 : 277–280. [PubMed] [Google Scholar]
  10. Horwitz JA, Halper-Stromberg A, Mouquet H, et al. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc Natl Acad Sci USA 2013 ; 110 : 16538–16543. [CrossRef] [Google Scholar]
  11. Peressin M, Holl V, Moog C. Les anticorps anti-VIH: multiples activités antivirales. Med Sci (Paris) 2014 ; 30 : 69–75. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.